Brodalumab is a medication that belongs to a class of drugs known as biologics, specifically targeting the interleukin-17 (IL-17) receptor. It is used to treat moderate to severe plaque psoriasis in adults who have not responded well to other treatments.

This medication works by blocking the action of IL-17, a protein in the body that plays a key role in the development of psoriasis. By inhibiting this protein, brodalumab helps to reduce inflammation and slow down the growth of skin cells, leading to improvements in psoriasis symptoms such as redness, itching, and scaling.

Brodalumab is typically administered as an injection under the skin, either by a healthcare provider or self-administered by the patient after proper training. It is important to follow the dosing schedule recommended by your healthcare provider to ensure the best results.

As with any medication, brodalumab may cause side effects in some individuals. Common side effects may include headache, fatigue, diarrhea, and upper respiratory tract infections. More serious side effects, such as allergic reactions or infections, may occur in rare cases and should be reported to your healthcare provider immediately.

It is important to discuss with your healthcare provider the potential benefits and risks of brodalumab before starting treatment. They can help determine if this medication is the right choice for you based on your individual medical history and needs.

Overall, brodalumab can be an effective treatment option for individuals with moderate to severe plaque psoriasis, providing relief from symptoms and improving quality of life. If you have any questions or concerns about this medication, do not hesitate to reach out to your healthcare provider for guidance and support.